Reference

Sikiric 2018 BPC-157 review

DOI: 10.2174/1381612824666171227213340
PubMed: 29278203
Verification: seed

Summary

Comprehensive review of BPC-157 across multiple animal models — accelerated healing of tendons, muscle, gut and bone injury via VEGF and NO pathway modulation.

Limitations

Almost entirely rodent data from a single research group in Zagreb; no published human trials; heterogeneous dose-response methodology.

Linked peptides

TB-500
BPC-157
GHK-Cu

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.